Aortic valve replacement for aortic stenosis after previous coronary artery bypass grafting: could early reoperation

Jean Ph Verhoye1, Franceseca Merlicco, Ibrahim M Sami

  • 1Department of Thoracic and Cardiovascular Surgery, University Hospital, Ponchaillou, Rennes, France. jean-philippe.verhoye@chu-rennes.fr

Insights

Aortic valve replacement (AVR) after coronary artery bypass graft (CABG) surgery carries high mortality if performed within five years. Consider AVR during CABG for select patients to improve outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Cardiac Valve Disease
  • Aortic Stenosis Management

Background:

  • Coronary artery bypass graft (CABG) surgery is often performed in patients with concomitant aortic stenosis (AS).
  • The optimal timing for aortic valve replacement (AVR) in patients who have undergone prior CABG is not well-defined.
  • Previous studies have not fully elucidated the risks associated with accelerated AS progression and outcomes after AVR in this patient cohort.

Purpose of the Study:

  • To retrospectively investigate the risk of accelerated aortic stenosis (AS) progression.
  • To evaluate the outcomes following aortic valve replacement (AVR) in patients with prior coronary artery bypass graft (CABG) surgery.
  • To identify predictors for AVR within five years of CABG.

Main Methods:

  • Retrospective analysis of 81 patients who underwent AVR for mild-to-moderate AS after initial CABG between 1994 and 2004.
  • Patients were stratified into three groups based on the time interval between CABG and AVR: <5 years, 5-10 years, and >10 years.
  • Multivariate analysis was employed to identify independent predictors of AVR timing and operative mortality.

Main Results:

  • Overall operative mortality after AVR was 16%, with significantly higher rates (30%) in patients undergoing AVR within five years of CABG.
  • Independent predictors for AVR within five years included a peak transvalvular gradient ≥30 mmHg, moderate calcifications with limited valve motion, and left ventricular hypertrophy (LVH).
  • Systemic vascular atherosclerotic disease predicted rapid AS progression and was a predictor of operative mortality.

Conclusions:

  • Due to high mortality associated with early repeat operations, AVR should be considered concurrently with CABG in select patients.
  • Recommended patient profile for concurrent AVR includes age ≤75 years, peak transvalvular gradient >30 mmHg, moderate calcifications with limited valve motion, and LVH.
  • This approach may mitigate risks associated with accelerated AS progression and improve long-term outcomes in patients requiring both procedures.
Abstract

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...